| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.086 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.065 | 0.6 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |